Literature DB >> 15631333

Antioxidants in the treatment of patients with renal failure.

M Luciak1.   

Abstract

Renal failure is accompanied by oxidative stress, which is caused by enhanced production of reactive oxygen species and impaired antioxidant defense. The suggested therapeutical interventions aimed at reducing oxidative stress in chronic renal failure patients are as follows: 1) the use of biocompatible membranes, ultrapure dialysate, and removal of endogenous foci of infection; 2) haemolipodialysis, and electrolysed reduced water for dialysate preparation; 3) administration of antioxidants (alpha-tocopherol, ascorbic acid, N-acetylcysteine, reduced glutathione); 4) substances possibly affecting oxidative stress indirectly (erythropoietin, sodium selenite). As currently available data have, as yet, provided rather limited evidence for the clinical benefit of antioxidant interventions, at present it is untimely to give practical recommendations with regard to antioxidant treatment of patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15631333

Source DB:  PubMed          Journal:  Rocz Akad Med Bialymst


  3 in total

1.  Administration of antioxidants in chronic kidney disease.

Authors:  Mohamad Reza Tamadon; Mehrdad Zahmatkesh; Seyed Seifollah Beladi Mousavi
Journal:  J Nephropharmacol       Date:  2015-01-01

2.  Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity.

Authors:  Mahmoud A Elfaky; Abrar K Thabit; Alaa Sirwi; Usama A Fahmy; Raghdah M Bahabri; Eman A Al-Awad; Lamis F Basaeed
Journal:  Antibiotics (Basel)       Date:  2019-11-25

3.  The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia.

Authors:  Dae Woong Kang; Chi Yong Ahn; Bong Kwan Ryu; Byung Chul Shin; Jong Hoon Chung; Hyun Lee Kim
Journal:  Kidney Res Clin Pract       Date:  2012-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.